Daklinza
Daklinza is a antivirals medication containing Daclatasvir, available as 60mg tablets.
- Category
- Antivirals
- Active ingredient
- Daclatasvir
- Route
- Oral use
- Form
- Film-coated tablet
- Strengths
- 60mg
You will receive a quality generic equivalent, depending on stock.
Prescription rules on Daklinza vary by country.
Details
- Conditions
- Chronic hepatitis c
- Therapeutic Class
- Direct-acting antiviral
- Pharmacological Class
- NS5A inhibitor
- Minor Side Effects
- headache, fatigue, nausea
- Moderate Side Effects
- anaemia, insomnia, diarrhoea
- Dosage Forms
- Film-coated tablet
- Administration Route
- Oral use
- Prescription Status
- Available without prescription
- Originator
- Bristol-Myers Squibb
- Onset Time
- Continuous therapy
- Duration
- 12–24 weeks
- Storage Instructions
- Store in a cool dry place.
- Drug Interactions
- amiodarone, carbamazepine, phenytoin
- Age Restrictions
- Adults
What you will receive
Daklinza is the originator brand name, made by Bristol-Myers Squibb. We use it here to identify the medicine only; we are not affiliated with Bristol-Myers Squibb and do not ship the original Daklinza.
- You receive a generic equivalent: the same active ingredient (Daclatasvir) at the same dose, mostly recognised Indian branded generics from vetted manufacturers.
- The exact brand supplied depends on what is in stock at the dispatching warehouse.
- A regulated generic matches the original ingredient for ingredient by legal standard.